The Lancet EDITORIAL| VOLUME 396, ISSUE 10263 , P1607, NOVEMBER 21, 2020 Excerpts The prospect of preventing illness and death, and avoiding the harm and misery of extended restrictions, is a cause for optimism. But although it is right to be hopeful and encouraged, we are far from ending COVID-19 as a public health issue. Pfizer and Moderna together project that there will be enough vaccine for 35 million individuals in 2020, and perhaps up to 1 billion in 2021. As a result, many millions...

A potential resolution is on the horizon, but for COVID-19 vaccination to work, people need to be willing to take the vaccines. Like many social scientists working in the fields of vaccine uptake and disaster response and recovery, we anticipated that widespread acceptance of COVID-19 vaccines would be a critical issue—an issue upon which the success of the vaccination campaign, and the solution to the pandemic, would hinge. That is what we are now seeing today.